Sellas Life Sciences Group Inc.
Featured video - SELLAS Reports Preliminary Data Showing Clinical[...]
Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal[...]
Safety and efficacy of pegunigalsidase alfa vs agalsidase beta on renal[...]
01/18/2022 | Press release | Distributed by Public on 01/18/2022 07:34
Please select the service you want to use:
Smartlinks | ReShape Lifesciences Inc. | News | Health | Local News | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Corporate and Financial Calendar | Pharmaceuticals | Media and Publishing | News Media | News Agencies | Casino and Gambling | Travel, Leisure and Recreation Industry | Public Companies | Biotechnology and Medical Research Companies | Börse Frankfurt | Börse Berlin | Börse München | Börse Stuttgart | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact